Recherche
-
Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON study
(Graefe's Archive for Clinical and Experimental Ophthalmology. vol. 258, n° 3, pp. 521-528, 2020)Article de revueLibre accès -
Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia
(Ophthalmology. vol. 126, n° 3, pp. 393-406, 2019-03)Article de revueLibre accès -
Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema
(Scientific Reports. vol. 12, n° 1, 2022-10-29)Article de revueLibre accès -
Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study
(Pharmaceutics. vol. 13, n° 2, 2021-02-01)Article de revueLibre accès -
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
(The Lancet. vol. 402, n° 10411, pp. 1434-1448, 2023-10-21)Article de revue -
The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus
(Current Opinion in Ophthalmology. vol. 34, n° 5, pp. 396-402, 2023-09-01)Article de revueLibre accès -
Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene
(The British journal of ophthalmology. vol. 103, n° 9, pp. 1239-1247, 2019-09)Article de revueLibre accès